Cerestat: Began a placebo-controlled safety trial using fixed doses instead of doses based on patients' weight, to run concomitantly with an on-going Phase II d

Cambridge Neuroscience Inc. (CNSI), Cambridge,

Read the full 57 word article

How to gain access

Continue reading with a
two-week free trial.